479 related articles for article (PubMed ID: 12022325)
1. Differences in the profiles of circulating levels of soluble tumor necrosis factor receptors and interleukin 1 receptor antagonist reflect the heterogeneity of the subgroups of juvenile rheumatoid arthritis.
Muzaffer MA; Dayer JM; Feldman BM; Pruzanski W; Roux-Lombard P; Schneider R; Laxer RM; Silverman ED
J Rheumatol; 2002 May; 29(5):1071-8. PubMed ID: 12022325
[TBL] [Abstract][Full Text] [Related]
2. Cytokine levels in serum and synovial fluid of patients with juvenile rheumatoid arthritis.
Madson KL; Moore TL; Lawrence JM; Osborn TG
J Rheumatol; 1994 Dec; 21(12):2359-63. PubMed ID: 7699643
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 8 and monocyte chemoattractant protein-1 in patients with juvenile rheumatoid arthritis. Relation to onset types, disease activity, and synovial fluid leukocytes.
De Benedetti F; Pignatti P; Bernasconi S; Gerloni V; Matsushima K; Caporali R; Montecucco CM; Sozzani S; Fantini F; Martini A
J Rheumatol; 1999 Feb; 26(2):425-31. PubMed ID: 9972980
[TBL] [Abstract][Full Text] [Related]
4. Differences in synovial fluid cytokine levels between juvenile and adult rheumatoid arthritis.
De Benedetti F; Pignatti P; Gerloni V; Massa M; Sartirana P; Caporali R; Montecucco CM; Corti A; Fantini F; Martini A
J Rheumatol; 1997 Jul; 24(7):1403-9. PubMed ID: 9228145
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
Seitz M; Zwicker M; Villiger PM
J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
[TBL] [Abstract][Full Text] [Related]
6. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity.
Gabay C; Cakir N; Moral F; Roux-Lombard P; Meyer O; Dayer JM; Vischer T; Yazici H; Guerne PA
J Rheumatol; 1997 Feb; 24(2):303-8. PubMed ID: 9034987
[TBL] [Abstract][Full Text] [Related]
7. Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations.
Foell D; Wittkowski H; Hammerschmidt I; Wulffraat N; Schmeling H; Frosch M; Horneff G; Kuis W; Sorg C; Roth J
Arthritis Rheum; 2004 Apr; 50(4):1286-95. PubMed ID: 15077313
[TBL] [Abstract][Full Text] [Related]
8. Contrasting cytokine profiles in the synovium of different forms of juvenile rheumatoid arthritis and juvenile spondyloarthropathy: prominence of interleukin 4 in restricted disease.
Murray KJ; Grom AA; Thompson SD; Lieuwen D; Passo MH; Glass DN
J Rheumatol; 1998 Jul; 25(7):1388-98. PubMed ID: 9676774
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1 receptor antagonist, soluble tumor necrosis factor-alpha receptor type I and II, and soluble E-selectin serum levels in multiple sclerosis patients receiving weekly intramuscular injections of interferon-beta1a.
Perini P; Tiberio M; Sivieri S; Facchinetti A; Biasi G; Gallo P
Eur Cytokine Netw; 2000 Mar; 11(1):81-6. PubMed ID: 10705303
[TBL] [Abstract][Full Text] [Related]
10. Elevated concentrations of monocyte derived cytokines in synovial fluid of children with enthesitis related arthritis and polyarticular types of juvenile idiopathic arthritis.
Saxena N; Aggarwal A; Misra R
J Rheumatol; 2005 Jul; 32(7):1349-53. PubMed ID: 15996076
[TBL] [Abstract][Full Text] [Related]
11. Increased circulating vascular endothelial growth factor is correlated with disease activity in polyarticular juvenile rheumatoid arthritis.
Maeno N; Takei S; Imanaka H; Takasaki I; Kitajima I; Maruyama I; Matsuo K; Miyata K
J Rheumatol; 1999 Oct; 26(10):2244-8. PubMed ID: 10529148
[TBL] [Abstract][Full Text] [Related]
12. Poly-C specific ribonuclease activity correlates with increased concentrations of IL-6, IL-8 and sTNFR55/sTNFR75 in plasma of patients with acute pancreatitis.
Naskalski JW; Kusnierz-Cabala B; Panek J; Kedra B
J Physiol Pharmacol; 2003 Sep; 54(3):439-48. PubMed ID: 14566081
[TBL] [Abstract][Full Text] [Related]
13. Elevated circulating interleukin-7 levels in patients with systemic juvenile rheumatoid arthritis.
De Benedetti F; Massa M; Pignatti P; Kelley M; Faltynek CR; Martini A
J Rheumatol; 1995 Aug; 22(8):1581-5. PubMed ID: 7473488
[TBL] [Abstract][Full Text] [Related]
14. Soluble adhesion molecules in juvenile rheumatoid arthritis.
Bloom BJ; Miller LC; Tucker LB; Schaller JG; Blier PR
J Rheumatol; 1999 Sep; 26(9):2044-8. PubMed ID: 10493690
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 1 (IL-1) receptor antagonist, soluble tumor necrosis factor receptors, IL-1 beta, and IL-8--markers of remission in rheumatoid arthritis during treatment with methotrexate.
Seitz M; Loetscher P; Dewald B; Towbin H; Rordorf C; Gallati H; Gerber NJ
J Rheumatol; 1996 Sep; 23(9):1512-6. PubMed ID: 8877917
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and concentration of IgM rheumatoid factor in polyarticular onset disease as compared to systemic or pauciarticular onset disease in active juvenile rheumatoid arthritis as measured by ELISA.
Walker SM; Shaham B; McCrudy DK; Wietting H; Arora YK; Hanson V; Bernstein B
J Rheumatol; 1990 Jul; 17(7):936-40. PubMed ID: 2213760
[TBL] [Abstract][Full Text] [Related]
17. Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patients.
Rogy MA; Coyle SM; Oldenburg HS; Rock CS; Barie PS; Van Zee KJ; Smith CG; Moldawer LL; Lowry SF
J Am Coll Surg; 1994 Feb; 178(2):132-8. PubMed ID: 8173722
[TBL] [Abstract][Full Text] [Related]
18. Effects of soluble TNF receptor II (sTNF-RII), IL-1 receptor antagonist (IL-1ra), tumor load and hypermetabolism on malnutrition in children with acute leukemia.
Schmid I; Schmitt M; Streiter M; Meilbeck R; Haas RJ; Stachel DK
Eur J Med Res; 2005 Nov; 10(11):457-61. PubMed ID: 16354598
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of hyaluronic acid indicate the severity of joint symptoms in patients with systemic and polyarticular juvenile rheumatoid arthritis.
Takei S; Imanaka H; Maeno N; Shigemori M; Masuda K; Hokonohara M; Miyata K
J Rheumatol; 1996 Nov; 23(11):1956-62. PubMed ID: 8923375
[TBL] [Abstract][Full Text] [Related]
20. Early predictors of longterm outcome in patients with juvenile rheumatoid arthritis: subset-specific correlations.
Oen K; Malleson PN; Cabral DA; Rosenberg AM; Petty RE; Reed M; Schroeder ML; Cheang M
J Rheumatol; 2003 Mar; 30(3):585-93. PubMed ID: 12610821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
